FDA panel rejects combination pain pill

Federal health advisers have unanimously rejected an experimental pain pill that combines two common opioids, oxycodone and morphine.

The , Moxduo, was developed by QRxPharma with the aim of decreasing dangerous side effects of , including , nausea and vomiting. The company theorized that combining lower doses of the two drugs would be safer and more effective than taking higher doses of the drugs separately.

But FDA advisers say that the company's studies of Moxduo did not show any advantages over regular oxycodone and morphine.

The FDA's 14 pain specialists all voted against approving the drug. The FDA is not required to follow the panel's recommendation.

A half-dozen public speakers urged the FDA to reject the drug at the Tuesday meeting, citing its potential for abuse.

3 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

FDA advisers unanimously back J&J hepatitis C drug

Oct 24, 2013

An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government experts who say the medication should be approved to treat patients infected with the liver-destroying virus.

US panel opposes pure hydrocodone painkiller

Dec 09, 2012

(AP)—U.S. government health experts overwhelmingly voted against a stronger version of hydrocodone on Friday, questioning the need for a new form of one of most widely abused prescription painkillers.

Recommended for you

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.